QNCX - Quince Therapeutics, Inc. Profit before interest, taxes and amortization

Brandmark of Quince Therapeutics, Inc. (QNCX)

Quince Therapeutics (QNCX) price action is driven by medical trial cycles for bone drug delivery systems. Growth potential is supported by leading scientists attracted by RSU packages and academic freedom. The pre-tax and depreciation profit volume on the GURU.Markets chart contains 0.00, which serves as the current parameter value. The EryDex platform, which utilizes erythrocytes for the gentle treatment of rare metabolic pathologies, confirms this efficiency.

Quince Therapeutics Inc - QNCX Operating profit EBITDA (period 11/23/2025 - 10/12/2026)

Summary analytical data breakdowns for Quince Therapeutics, Inc. (QNCX)

- current quotes and average value forecast:
Analysis of all company metrics:quincetx.com (QNCX)
Manufactured products of quincetx.com

This indicator measures operating cash flow before depreciation and taxes, allowing for an assessment of the business's actual ability to generate profit from its core operations. Analyzing the absolute operating profit of Quince Therapeutics (QNCX) in monetary terms helps identify hidden vulnerabilities, which is critical for Quince Therapeutics (QNCX), as its model of outsourcing production to CDMO plants minimizes capital expenditures but requires strict control over operational efficiency.

Who Quince Therapeutics competes with

ASND - Operating profit before deduction of amortization|Madrigal Corp - Operating profit EBITDA|Profit before interest, taxes and amortization Corcept|RYTM (Rhythm Pharmaceuticals, Inc.) - Operating profit before deduction of amortization|AKRO: Company profit before taxes, interest and amortization|MTSR (Metsera Therapeutics) - Operating profit EBITDA|Operating profit EBITDA MoonLake Immunotherapeutics|Operating profit EBITDA CRNX|Profit before payment of interest, taxes and amortization NAMS (NewAmsterdam Pharma Company)|Profit before payment of interest, taxes and amortization soleno.life SLNO|Amicus Corp (FOLD) - Profit before interest, taxes and amortization|ETNB - Profit before payment of interest, taxes and amortization|AGIO: Profit before payment of interest, taxes and amortization|GPCR: Operating profit EBITDA|MDXG - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization Rezolute Bio|Lexicon Corp (LXRX) - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization mbxbio.com (MBX)|Operating profit EBITDA altimmune.com (ALT)|Operating profit EBITDA AARD (aardvarktherapeutics.com)|Operating income before deduction of amortization Sagimet Biosciences Inc. (SGMT)|BioAge Labs, Inc - Operating profit EBITDA|Operating income before deduction of amortization Biomea Fusion Corp BMEA|GUTS: Operating profit EBITDA|VTVT (vTv Therapeutics Inc.) - Profit before payment of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Agape ATP Corp.|PLUR: Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Synlogic, Inc. (SYBX)|Operating profit before deduction of amortization Lipocine Corp LPCN|Operating profit EBITDA MTNB (Matinas BioPharma Holdings, Inc.)|Spruce Biosciences (SPRB) - Profit before interest, taxes and amortization|GLTO - Profit before payment of interest, taxes and amortization|CTCX: Profit before payment of interest, taxes and amortization|LUMO: Operating profit EBITDA|Profit before interest, taxes and amortization Organovo Holdings, Inc. (ONVO)|RDUS (Radius Recycling Inc.) - Operating profit EBITDA